cadralazine (Q3649490)

cadralazine (English)

14 October 2016

chemical formula

C₁₂H₂₁N₅O₃

1 reference

cadralazine (English)

14 October 2016

canonical SMILES

CCN(CC(C)O)C1=NN=C(C=C1)NNC(=O)OCC

1 reference

cadralazine (English)

https://www.whocc.no/atc_ddd_index/?code=C02DB04

14 October 2016

defined daily dose

15 milligram

route of administration

oral administration

1 reference

reference URL

subject has role

antihypertensive drug

1 reference

InChI=1S/C12H21N5O3/c1-4-17(8-9(3)18)11-7-6-10(13-15-11)14-16-12(19)20-5-2/h6-7,9,18H,4-5,8H2,1-3H3,(H,13,14)(H,16,19)

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

15 March 2018

Cadralazine

0 references

Identifiers

InChI

1 reference

cadralazine (English)

14 October 2016

2 references

cadralazine (English)

14 October 2016

ChEBI release 2020-09-01

CAS Registry Number

64241-34-5

2 references

Global Substance Registration System

UNII

8T96I3U713

https://commonchemistry.cas.org/detail?cas_rn=64241-34-5

cadralazine (English)

14 October 2016

6 April 2021

1 reference

Cadralazine (English)

14 October 2016

2 references

cadralazine (English)

14 October 2016

ChEBI ID

31331

mapping relation type

exact match

2 references

ChEBI release 2019-10-02

International Chemical Identifier

InChI

InChI=1S/C12H21N5O3/c1-4-17(8-9(3)18)11-7-6-10(13-15-11)14-16-12(19)20-5-2/h6-7,9,18H,4-5,8H2,1-3H3,(H,13,14)(H,16,19)

1 reference

CADRALAZINE (English)

14 October 2016

2 references

inferred from InChIKey

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

1 reference

2 references

DSSTOX compound identifier

0 references

0 references

1 reference

Medical Subject Headings

14 March 2018

1 reference

Human Metabolome Database ID

HMDB0041845

2 references

based on heuristic

inferred from InChIKey

UNII

8T96I3U713

2 references

Global Substance Registration System

UNII

8T96I3U713

cadralazine (English)

14 October 2016